MeCP2 Epigenetic Silencing of Oprm1 Gene in Primary Sensory Neurons Under Neuropathic Pain Conditions
Opioids are the last option for the pharmacological treatment of neuropathic pain, but their antinociceptive effects are limited. Decreased mu opioid receptor (MOR) expression in the peripheral nervous system may contribute to this. Here, we showed that nerve injury induced hypermethylation of the O...
Main Authors: | Na Sun, Lina Yu, Yibo Gao, Longfei Ma, Jinxuan Ren, Ying Liu, Dave Schwinn Gao, Chen Xie, Ying Wu, Lieju Wang, Juncong Hong, Min Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2021.743207/full |
Similar Items
-
The Epigenetics of Neuropathic Pain: A Systematic Update
by: Gábor Pethő, et al.
Published: (2023-12-01) -
Bioinformatics Analysis Identifies p53 as a Candidate Prognostic Biomarker for Neuropathic Pain
by: Yibo Gao, et al.
Published: (2018-08-01) -
NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel
by: Meng Liu, et al.
Published: (2020-10-01) -
DNMT3a methylation in neuropathic pain
by: Shao CJ, et al.
Published: (2017-09-01) -
Anti-allodynic Effect of Nefopam and Morphine in a Rat Model of Neuropathic Pain
by: Taraneh Moini Zanjani, et al.
Published: (2013-05-01)